SCHEMBL23619483

SCHEMBL23619483

NNn1cnc2c(=O)n3cc[nH]c3nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362231 0.78 CDK1 (0.36) —
SCHEMBL21372042 0.75 PI4KA (0.37) —
SCHEMBL21871805 0.75 CDK1 (0.42) —
SCHEMBL30089497 0.70 — —
SCHEMBL21137208 0.66 XDH (0.55) —
SCHEMBL21127785 0.65 HPRT1 (0.48) —
SCHEMBL22399377 0.65 XDH (0.38) —
SCHEMBL22326694 0.61 JAK2 (0.34) —
SCHEMBL1576524 0.61 ALDH1A1 (0.41) —
SCHEMBL1033720 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685761-B2 Cyclic di-nucleotide compounds as sting agonists MERCK SHARP & DOHME LLC (US) 2023-06-27 — — US disclosed
US-20210206796-A1 CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS MERCK SHARP & DOHME CORP. (US) 2021-07-08 — — US disclosed
Send feedback